145 related articles for article (PubMed ID: 436307)
21. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH.
Coiro V; Volpi R; Cataldo S; Capretti L; Caffarri G; Pilla S; Chiodera P
J Investig Med; 2000 Mar; 48(2):133-6. PubMed ID: 10736973
[TBL] [Abstract][Full Text] [Related]
22. Evidence for endogenous dopaminergic regulation of thyrotropin (TSH) secretion in man.
Sasaki A; Hanew K; Sato S; Yoshinaga K
Tohoku J Exp Med; 1983 Jan; 139(1):1-7. PubMed ID: 6836556
[TBL] [Abstract][Full Text] [Related]
23. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.
Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M
Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143
[TBL] [Abstract][Full Text] [Related]
24. Effects of metoclopramide on fasting-induced TSH suppression.
Samuels MH; Kramer P
Thyroid; 1996 Apr; 6(2):85-9. PubMed ID: 8733877
[TBL] [Abstract][Full Text] [Related]
25. Influence of central dopaminergic activity on thyrotropin responsiveness to thyrotropin-releasing hormone in normal and thyrotoxic subjects.
Röjdmark S
Horm Metab Res; 1986 Jun; 18(6):407-10. PubMed ID: 3089893
[TBL] [Abstract][Full Text] [Related]
26. Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism.
Lombardi G; Iodice M; Miletto P; Merola B; Panza N; Annunziato L
Neuroendocrinology; 1986; 43(6):676-8. PubMed ID: 3093910
[TBL] [Abstract][Full Text] [Related]
27. Prolactin response to metoclopramide in hyperthyroidism.
Sawers JS; Kellett HA; Brown NS; Seth J; Toft AD
J Clin Endocrinol Metab; 1982 Jul; 55(1):175-7. PubMed ID: 6804483
[TBL] [Abstract][Full Text] [Related]
28. Evidence for dopaminergic control of thyrotrophin secretion in man.
Scanlon MF; Weightman DR; Mora B; Heath M; Shale DJ; Snow MH; Hall R
Lancet; 1977 Aug; 2(8035):421-3. PubMed ID: 70641
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women.
Rossmanith WG; Mortola JF; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1988 Sep; 67(3):560-4. PubMed ID: 3410940
[TBL] [Abstract][Full Text] [Related]
30. Dopamine in the pituitary adaptation to starvation in man.
Jung RT; Rosenstock J; Wood SM; Birch G; Chalmers RA; Mashiter K; Joplin GF
Postgrad Med J; 1985 Jul; 61(717):571-4. PubMed ID: 3927279
[TBL] [Abstract][Full Text] [Related]
31. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.
Agner T; Hagen C; Andersen AN; Djursing H
J Clin Endocrinol Metab; 1986 Apr; 62(4):778-82. PubMed ID: 3949956
[TBL] [Abstract][Full Text] [Related]
32. Aldosterone responsiveness to metoclopramide in hyperprolactinaemia.
O'Malley BP; Mercey D; Clarke E; Maguire M; Jackson J; Rosenthal FD
Clin Sci (Lond); 1987 Mar; 72(3):277-82. PubMed ID: 3816084
[TBL] [Abstract][Full Text] [Related]
33. Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma.
Quigley ME; Yen SS
Am J Obstet Gynecol; 1980 Jul; 137(6):653-5. PubMed ID: 7395929
[TBL] [Abstract][Full Text] [Related]
34. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
Andreassen B; Huth J; Tyson JE
Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
[TBL] [Abstract][Full Text] [Related]
35. Reduced dopaminergic inhibition of thyrotrophin release in states of physiological hyperprolactinaemia.
Rodriguez-Arnao MD; Weightman DR; Hall R; Scanlon MF; Camporro JM; Gomez-Pan A
Clin Endocrinol (Oxf); 1982 Jul; 17(1):15-9. PubMed ID: 7116653
[TBL] [Abstract][Full Text] [Related]
36. Effects of vitamin A administration on serum thyrotropin concentrations in healthy human subjects.
Ceresini G; Rebecchi I; Morganti S; Maggio M; Solerte SB; Corcione L; Izzo S; Mecocci P; Valenti G
Metabolism; 2002 Jun; 51(6):691-4. PubMed ID: 12037720
[TBL] [Abstract][Full Text] [Related]
37. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle.
Seki K; Nagata I
Acta Endocrinol (Copenh); 1990 Feb; 122(2):211-6. PubMed ID: 2107654
[TBL] [Abstract][Full Text] [Related]
38. Effect of low-dose dopamine infusion on basal and stimulated TSH and prolactin concentrations in man.
Connell JM; Ball SG; Balmforth AJ; Beastall GH; Davies DL
Clin Endocrinol (Oxf); 1985 Aug; 23(2):185-92. PubMed ID: 3931943
[TBL] [Abstract][Full Text] [Related]
39. [Effect of the dopamin antagonist metoclopramide on the TSH response after oral TRH in the TSH suppression syndrome ("preclinical hyperthyroidism"). Preliminary report].
Birkhäuser MH; Staub JJ; Gräni R; Girard J; Good E
Schweiz Med Wochenschr; 1980 Dec; 110(49):1877-9. PubMed ID: 6779375
[TBL] [Abstract][Full Text] [Related]
40. Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman.
Custro N; Scafidi V; Notarbartolo A
J Endocrinol Invest; 1992 Feb; 15(2):121-6. PubMed ID: 1569287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
